Akihiko Ozaki, M.D., Ph.D. Physician at the Medical Governance Research Institute "We are taking this drug off the market because we cannot prove its effectiveness." Cancer treatment drugs that were deemed this way in the United States are still used as "recommended treatments" in Japan. At least seven cases have been confirmed as of July 2023. This surprising fact was revealed by the authors' latest research, accepted for publication in “Investigational New Drugs” and is due

Mr. Keita Shimizu, Science Class III, The University of Tokyo, 1st year As I was rocked on the Yamanote Line as it traveled through Tokyo late at night, I was left with two conflicting emotions. One was a sense elation. The other was a sense self-reflection. I had the opportunity to participate as a student staff member in the 19th Symposium of the Council for Promoting Medical Reform from the Field on November 16th and 17th last year. I entered the University of Tokyo in Apr